Structure Therapeutics Quarterly Balance Sheet
NASDAQ: GPCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Structure Therapeutics financial position
As of Jun 30, 2026, Structure Therapeutics reported total assets of $1.43 billion, up 74.6% from a year earlier against total liabilities of $71.0 million. Shareholders' equity stood at $1.35 billion, or 95.0% of assets. The company held $272.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 20.75, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Structure Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 272.64M | 316.17M | 799.62M | 102.91M | 147.02M | 152.12M | 169.51M | 172.13M | 381.63M | 97.83M | 129.79M | 50.64M |
| Short-Term Investments | 1.07B | 1.14B | 646.57M | 696.13M | 639.47M | 684.76M | 714.01M | 743.16M | 545.49M | 338.62M | 337.53M | 154.79M |
| Total Current Assets | 1.37B | 1.49B | 1.57B | 814.02M | 799.30M | 849.62M | 891.21M | 923.65M | 937.62M | 449.36M | 473.61M | 209.96M |
| Property, Plant & Equipment | 6.33M | 6.37M | 6.65M | 4.67M | 3.46M | 3.52M | 3.48M | 3.73M | 3.31M | 3.12M | 3.23M | 2.41M |
| Total Assets | 1.43B | 1.51B | 1.58B | 832.16M | 816.44M | 866.55M | 903.33M | 933.22M | 947.03M | 457.23M | 482.02M | 216.37M |
| Accounts Payable | 11.13M | 7.82M | 13.86M | 17.80M | 8.99M | 8.71M | 8.02M | 8.45M | 2.21M | 6.54M | 4.74M | 3.32M |
| Total Current Liabilities | 66.11M | 56.98M | 63.28M | 57.53M | 39.03M | 36.49M | 36.02M | 33.43M | 22.66M | 23.59M | 24.74M | 20.09M |
| Total Liabilities | 71.01M | 61.03M | 67.54M | 62.14M | 44.36M | 41.91M | 38.49M | 36.42M | 26.00M | 27.41M | 29.05M | 23.41M |
| Shareholders' Equity | 1.35B | 1.45B | 1.52B | 770.02M | 772.08M | 824.64M | 864.84M | 896.80M | 921.03M | 429.82M | 452.97M | 192.96M |
| Retained Earnings | -652.43M | -546.27M | -470.30M | -503.30M | -437.59M | -375.93M | -329.10M | -292.62M | -258.64M | -232.61M | -206.57M | -182.07M |
| Net Cash (Debt) | 1.34B | 1.46B | 1.45B | 799.04M | 786.50M | 836.88M | 883.52M | 915.29M | 927.12M | 436.45M | 467.32M | 205.42M |
| Shares Outstanding | 213.66M | 213.21M | 212.51M | 182.03M | 172.70M | 172.61M | 171.86M | 171.76M | 171.59M | 139.85M | 139.22M | — |
This table shows 12 quarterly periods of Structure Therapeutics's balance sheet, from Q2 2026 back to Q3 2023, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow GPCR's reporting calendar. What is a balance sheet?